A Multibiomarker Risk Score Helps Predict Risk for Barrett'sEsophagus

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 8, 2014, Pages 1267-1271

  Thrift, Aaron P ^a,b   Garcia, Jose M ^c   El Serag, Hashem B ^c,d  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b Fred Hutchinson Cancer Research Center   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Houston Veterans Affairs Health Services Research and Development Center of Excellence   (United States)

Author keywords

Barrett's Esophagus; Biomarkers; Cytokines; Risk Prediction

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 16; INTERLEUKIN 8; LEPTIN; BIOLOGICAL MARKER; INTERLEUKIN 6;

ARTICLE; BARRETT ESOPHAGUS; CALIBRATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE DURATION; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIBIOMARKER RISK SCORE; RACE DIFFERENCE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; VETERAN; WAIST HIP RATIO; ADULT; AGED; ANTHROPOMETRY; BLOOD; CASE CONTROL STUDY; DEMOGRAPHY; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; VERY ELDERLY; CAUCASIAN; NONHUMAN; PREDICTION; RACE;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BARRETT ESOPHAGUS; BIOMARKERS; CASE-CONTROL STUDIES; CYTOKINES; DEMOGRAPHY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LEPTIN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 84904391050     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.12.014     Document Type: Article

References (17)

1. Thrift A.P., Whiteman D.C. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 2012, 23:3155-3162.
2. van Soest E.M., Dieleman J.P., Siersema P.D., et al. Increasing incidence of Barrett's oesophagus in the general population. Gut 2005, 54:1062-1066.
3. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. NEngl J Med 1999, 340:825-831.
4. Lieberman D.A., Oehlke M., Helfand M. Risk factors for Barrett's esophagus in community-based practice. Am J Gastroenterol 1997, 92:1293-1297.
5. Hampel H., Abraham N.S., El-Serag H.B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005, 143:199-211.
6. Singh S., Sharma A.N., Murad M.H., et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013, 11:1399-1412.
7. Duggan C., Onstad L., Hardikar S., et al. Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2013, 11:934-943.
8. El-Serag H.B., Hashmi A., Garcia J., et al. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut 2014, 63:220-229.
9. Kramer J.R., Fischbach L.A., Richardson P., et al. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol 2013, 11:373-381.
10. Garcia J.M., Splenser A.E., Kramer J., et al. Circulating inflammatory cytokines and adipokines are associated with Barrett's esophagus: a case-control study. Clin Gastroenterol Hepatol 2014, 12:229-238.
11. Thrift A.P., Kendall B.J., Pandeya N., et al. Aclinical risk prediction model for Barrett esophagus. Cancer Prev Res (Phila) 2012, 5:1115-1123.
12. Rubenstein J.H., Morgenstern H., Appelman H., et al. Prediction of Barrett's esophagus among men. Am J Gastroenterol 2013, 108:353-362.
13. Gerson L.B., Edson R., Lavori P.W., et al. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 2001, 96:2005-2012.
14. Locke G.R., Zinsmeister A.R., Talley N.J. Can symptoms predict endoscopic findings in GERD?. Gastrointest Endosc 2003, 58:661-670.
15. Locke G.R., Talley N.J., Weaver A.L., et al. Anew questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994, 69:539-547.
16. Thrift A.P., Kramer J.R., Richardson P.A., et al. No significant effects of smoking or alcohol consumption on risk of Barrett's esophagus. Dig Dis Sci 2014, 59:108-116.
17. El-Serag H.B., Sweet S., Winchester C.C., et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014, 63:871-880.